Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and, at higher doses (as Wegovy), for weight management in adults with obesity
The copper peptide group showed faster initial improvements in the early weeks
The commission that oversees health insurance for state employees has voted to end coverage of GLP-1 drugs for weight loss, a decision driven by soaring costs that officials say are straining the state budget
A food tolerance response or a food allergy (food intolerance) can occur at this stage (178)
Continue quarterly check-ins and annual bloodwork
Eligibility criteria for Blue Cross Blue Shield coverage for therapy To access therapy through BCBS, you generally need to have an active BCBS insurance plan, choose an in-network licensed provider, and, in many cases, have a formal mental health diagnosis